← Back to Treatments
🏅 FDA Orphan Designation

Aurlumyn

iloprost

Manufacturer: BTG International Inc.

Indicated for:
Testicular teratomaOrphanSevere phosphoribosylpyrophosphate synthetase superactivity

FDA-Approved Indications (2)

Testicular teratomaOrphan Designation

treatment of severe frostbite in adults to reduce the risk of digit amputations

AURLUMYN is indicated for the treatment of severe frostbite in adults to reduce the risk of digit amputations

Population: adults

Indications & Usage

1 INDICATIONS AND USAGE AURLUMYN is a prostacyclin mimetic indicated for the treatment of severe frostbite in adults to reduce the risk of digit amputations. Effectiveness was established in young, healthy adults who suffered frostbite at high altitudes ( 1.1 ). 1.1 Frostbite AURLUMYN is indicated for the treatment of severe frostbite in adults to reduce the risk of digit amputations. Effectiveness was established in young, healthy adults who suffered frostbite at high altitudes.

💙 Support Programs

View all →
Aurlumyn
BTG International Inc.

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.